Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > Viacycte reports positive results from study

<< Previous

Bullboard Posts

Next >>

Comment by Metalsguy1on Dec 04, 2021 4:36pm

178 Views

Post# 34198901

RE:RE:RE:RE:Viacycte reports positive results from study

On the surface the promotion of FH appears to be positive to the uninformed but at a deeper level it could mean that even the Board has recognized that management is not getting the job done in terms of deals.

<< Previous

Bullboard Posts

Next >>

Calibre discovers significant gold in Newfoundland